Today gamers can join in the celebration of 50 years of James Bond with the release of 007™ Legends from Activision Publishing, Inc., a wholly owned subsidiary of Activision Blizzard Inc., (Nasdaq: ATVI). Available at North American retail outlets today, across Europe on October 19th and in Australia on October 31st, 007 Legends is the latest installment in the esteemed franchise, delivering a first-of-its-kind Bond video game experience featuring a story inspired by five classic Bond films – Goldfinger, On Her Majesty’s Secret Service, Moonraker, Licence to Kill, Die Another Day. Additionally, 007 Legends will feature a sixth mission based on this year’s highly anticipated Bond film – SKYFALL – which will be available to unlock as downloadable content. Timed to the North American release of the feature film, PlayStation®Network subscribers will gain exclusive early access to the SKYFALL mission on November 9, 2012, and then on November 20, 2012, the mission will be available on Xbox LIVE® online entertainment network.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58457-activision-publishing-50-years-of-james-bond-007-legends-video-game
The Brown Mackie College system of schools (“Brown Mackie College”), a college of Education Management Corporation (NASDAQ:EDMC), is adopting technology into education, converting students at its 28 schools nationwide to 100 percent e-textbooks and Apple iPad technology. Through the college’s Student Advantage Program, each incoming student will receive an iPad with the applications and textbooks necessary to make the technology a key part of their overall educational experience.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59095-brown-mackie-college-system-conversion-to-e-textbooks-ipad-nationwide
To most technologists, cloud computing is about applications, servers, storage and connectivity. To Texas Instruments Incorporated (TI) (NASDAQ: TXN) it means much more. Today, TI is unveiling a BETTER way to cloud with six new multicore System-on-Chips (SoCs). Based on its award winning KeyStone architecture, TI’s SoCs are designed to revitalize cloud computing, inject new verve and excitement into pivotal infrastructure systems and, despite their feature rich specifications and superior performance, actually reduce energy consumption.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54044-texas-instruments-keystone-multicore-socs-revitalize-cloud-applications
Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced today that the European Commission has granted marketing authorization to Constella® (linaclotide 290mcg) for the symptomatic treatment of moderate to severe Irritable Bowel Syndrome with Constipation (IBS-C) in adults . This approval follows the positive recommendation received from the European Committee for Medicinal Products for Human Use (CHMP) in September.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58658-almirall
As a new survey conducted online by Harris Interactive on behalf of Nutrisystem among over 3,000 U.S adults in December, indicates more than half of Americans (54 percent) are planning to make New Year’s resolutions to lose weight. Nutrisystem (NASDAQ: NTRI), the leading provider of home-delivered weight loss meal plans, is gearing up to help them succeed in keeping those resolutions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59643-nutrisystem-survey-weight-loss-new-year-s-resolutions
Symmetricom®, Inc. (NASDAQ: SYMM), a worldwide leader in precision time and frequency technologies, today announced a new timing solution that meets the stringent microsecond accuracy requirements of Smart Grid substations. Specifically designed for substation operations, such as wide area measurement systems, traveling wave fault locators and sampled values, the Symmetricom SyncServer SGC-1500 Smart Grid Clock offers power utility companies accurate, secure and reliable timing and synchronization for their mission-critical operations. This means companies like Pacific Gas & Electric (PG&E) will be able to mitigate outages with real-time monitoring for grid stress, frequency instability, voltage instability and reliability margins.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60168-symmetricom-next-generation-syncserver-sgc-1500-smart-grid-clock-utilities
WebMD Health Corp. (Nasdaq: WBMD), the leading source of health information, announced today its new WebMD Allergy app for the iPhone, an innovative new mobile resource that empowers consumers to take control of their allergies. It is the first free app to provide allergy sufferers with personalized location-based allergy condition forecasts in combination with WebMD’s trusted information and insights. WebMD Allergy is further personalized with optional mobile push notifications that warn when allergen levels are high, enabling app users to proactively manage their allergy conditions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60044-webmd-introduces-new-allergy-app-for-iphone
WebMD Health Corp. (Nasdaq: WBMD), the leading source of health information, announced today the launch of the WebMD Pregnancy app, a free iPhone® app offering expectant moms WebMD’s physician-reviewed pregnancy information that is customizable to fit a woman’s unique pregnancy. The WebMD Pregnancy App is WebMD’s latest addition to its multi-screen platform approach which provides actionable health information when consumers want it most, enabling them to better manage their health. WebMD is the leader in mobile for health information, with WebMD’s mobile apps for consumers having been downloaded over 16 million times.1
To view Multimedia News Release, go to http://www.multivu.com/mnr/60045-webmd-launches-new-pregnancy-app-for-iphone
1appFigures data through December 26, 2012; includes WebMD App, WebMD Baby App, WebMD Pain Coach App
Solta Medical, Inc. (Nasdaq: SLTM), the global market leader in aesthetic skin treatments, today announced the launch of the Simply Smart Rewards Program for Clear + Brilliant laser treatments, the first-ever patient loyalty program in aesthetic laser skin resurfacing.
Clear + Brilliant and Clear + Brilliant Perméa treatments have been shown to help improve skin tone, texture and other subtle signs of aging. The precise laser energy has allowed most consumers to experience immediate and progressive results that last for months, but vary by age, skin condition and how they protect their skin. The treatment takes about 20 minutes, is safe for all skin types and is suitable for men and women.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61178-solta-medical-launches-clear-brilliant-simply-smart-rewards-program
Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq: RPTP), today announced that the U.S. Food and Drug Administration (FDA) has approved PROCYSBI™ (cysteamine bitartrate) delayed release capsules for the treatment of nephropathic cystinosis in adults and children 6 years and older. In a Phase 3 study, PROCYSBI showed consistent cystine depletion over the full 12-hour dosing period. Sustained levels of cysteamine have not historically been achieved in the majority of patients in this population. Studies have shown that sustained cystine depletion in patients may significantly delay disease progression, including kidney dysfunction, dialysis, kidney transplant, organ failure and premature death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61338-raptor-pharmaceutical-procysbi-fda-approval-nephropathic-cystinosis
Destination XL Group, Inc. (NASDAQ: DXLG), the leading retailer of men’s XL apparel and accessories, launched a new national advertising campaign designed to draw attention to the many challenges men who wear XL sizes face when shopping for clothes and position Destination XL (DXL) as the one-stop-shopping solution for the style needs of this underserved consumer.
The TV and radio spots, titled “No Man’s Land”, use humor to underscore the shared and relatable shopping frustrations bigger guys face, and remind them that Destination XL is committed to addressing their fashion needs.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61481-destination-xl-national-ad-campaign-to-support-major-retail-expansion
In recognition of Melanoma Monday® and National Melanoma/Skin Cancer Detection & Prevention MonthTM, MELA Sciences, Inc. (NASDAQ: MELA) visited the NASDAQ MarketSite in Times Square today to ring the Opening Bell and sponsor free skin cancer checks.
One American dies every hour from melanoma, the most deadly skin cancer. MELA Sciences, Inc. is the pioneer company behind MelaFind®, the first and only FDA-approved diagnostic tool that helps dermatologists detect melanoma at its most curable stage. MelaFind® was approved by the U.S. Food & Drug Administration (FDA) in Fall 2011, and since then has strategically rolled out the technology to dermatology practices across the country.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61584-mela-sciences-rings-opening-bell-awareness-melanoma-detection-prevention
